EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSEEEG00000015260
Gene Symbol: GRIA2A
4 Cross references
244 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSEEEG00000012793
Gene Symbol: GRIA2B
4 Cross references
257 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 3b

Ensembl ID : ENSEEEG00000008563
Gene Symbol: GRIA3B
4 Cross references
198 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSEEEG00000003092
Gene Symbol: GRIA4B
4 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSEEEG00000003582
Gene Symbol: GRIN1A
2 Cross references
205 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSEEEG00000020142
Gene Symbol: GRIN1B
2 Cross references
152 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSEEEG00000019783
Gene Symbol: GRIN2BB
2 Cross references
256 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSEEEG00000003809
Gene Symbol: GRIK5
4 Cross references
288 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSEEEG00000009859
Gene Symbol: GRM2B
4 Cross references
210 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSEEEG00000010500
Gene Symbol: GRM3
4 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSEEEG00000012181
Gene Symbol: GRM5A
4 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSEEEG00000001327
Gene Symbol: GRM5B
4 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).